Genasys Inc. Files Q3 2024 10-Q Report

TL;DR

Genasys Q3 10-Q filed Aug 6. Financials for period ending June 30, 2024.

AI Summary

Genasys Inc. filed its Q3 2024 10-Q report on August 6, 2024, covering the period ending June 30, 2024. The company, formerly known as LRAD Corp and American Technology Corp, is based in San Diego, CA. The filing details financial performance and operational updates for the third quarter of fiscal year 2024.

Why It Matters

This filing provides investors with the latest financial and operational data for Genasys Inc., crucial for understanding the company's performance and future prospects.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or unusual disclosures.

Key Players & Entities

• Genasys Inc. (company) — Filer
• LRAD Corp (company) — Former company name
• AMERICAN TECHNOLOGY CORP /DE/ (company) — Former company name
• San Diego, CA (location) — Business and Mail Address City/State
• 08/06/2024 (date) — Filing Date
• 06/30/2024 (date) — Fiscal Period End Date

FAQ

Key Financial Figures

• $0.00001 — ecurities are registered Common stock, $0.00001 par value per share GNSS NASDAQ Cap

Filing Documents

• gnss20240630_10q.htm (10-Q) — 2165KB
• ex_706690.htm (EX-31.1) — 13KB
• ex_706691.htm (EX-31.2) — 13KB
• ex_706692.htm (EX-32.1) — 6KB
• logo01.jpg (GRAPHIC) — 13KB
• 0001437749-24-024913.txt ( ) — 11947KB
• gnss-20240630.xsd (EX-101.SCH) — 95KB
• gnss-20240630_def.xml (EX-101.DEF) — 691KB
• gnss-20240630_lab.xml (EX-101.LAB) — 529KB
• gnss-20240630_pre.xml (EX-101.PRE) — 734KB
• gnss-20240630_cal.xml (EX-101.CAL) — 64KB
• gnss20240630_10q_htm.xml (XML) — 2470KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Genasys Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par value and share amounts) June 30, 2024 September 30, (Unaudited) 2023 ASSETS Current assets: Cash and cash equivalents $ 8,672 $ 8,665 Short-term marketable securities 4,046 1,481 Restricted cash - 758 Accounts receivable, net of allowance for credit losses of $ 65 5,661 5,952 Inventories, net 7,315 6,501 Prepaid expenses and other 5,927 1,851 Total current assets 31,621 25,208 Long-term restricted cash 346 96 Property and equipment, net 1,373 1,551 Goodwill 13,235 10,282 Intangible assets, net 9,123 8,427 Operating lease right of use assets 3,307 3,886 Other assets 404 455 Total assets $ 59,409 $ 49,905 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 3,562 $ 2,785 Accrued liabilities 7,683 7,466 Operating lease liabilities, current portion 1,026 1,008 Total current liabilities 12,271 11,259 Notes payable, at fair value 11,699 - Warrant liability 3,104 - Other liabilities, noncurrent 343 551 Operating lease liabilities, noncurrent 3,518 4,283 Total liabilities 30,935 16,093 Stockholders' equity: Preferred stock, $ 0.00001 par value; 5,000,000 shares authorized; none issued and outstanding - - Common stock, $ 0.00001 par value; 100,000,000 shares authorized; 44,604,014 and 37,211,071 shares issued and outstanding, respectively - - Additional paid-in capital 125,350 110,379 Accumulated deficit ( 96,406 ) ( 76,062 ) Accumulated other comprehensive loss ( 470 ) ( 505 ) Total stockholders' equity 28,474 33,812 Total liabilities and stockholders' equity $ 59,409 $ 49,905 See accompanying notes 1 Genasys Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share and share amounts) (Unaudited) Three Months Ended Nine Months En

View Full Filing

View this 10-Q filing on SEC EDGAR